Biotech - Drug Development

Biotechnology companies developing novel therapeutics across disease areas (excluding oncology-focused)
LLYLLYEli Lilly & Co.
Metabolic & Cardiometabolic
$1.3t$1347.00-0.2%2.5M
JNJJNJJohnson & Johnson
Immunology & Autoimmune
$0.6t$270.75+1.3%8.1M
ABBVABBVABBVIE INC.
Immunology & Autoimmune
$0.5t$285.95+0.9%5.3M
MRKMRKMerck & Co., Inc.
Infectious Disease & Vaccines
$356.9b$134.06+1.1%11.2M
AZNAZNAstraZeneca PLC
Metabolic & Cardiometabolic
$285.2b$173.77-0.6%1.7M
TMOTMOThermo Fisher Scientific, Inc.
Clinical-Stage Platforms
$258.7b$678.26-2.8%1.9M
AMGNAMGNAmgen Inc
Rare Disease TherapeuticsImmunology & Autoimmune
$249.4b$438.02-0.6%2.7M
GILDGILDGilead Sciences Inc
Infectious Disease & Vaccines
$207.7b$167.22-0.1%5.0M
PFEPFEPfizer Inc.
Infectious Disease & Vaccines
$171.0b$27.43-0.4%26.6M
VRTXVRTXVertex Pharmaceuticals Inc
Rare Disease Therapeutics
$134.5b$516.00-1.1%1.2M
BMYBMYBristol-Myers Squibb Co.
Immunology & Autoimmune
$126.1b$59.00+1.1%9.4M
REGNREGNRegeneron Pharmaceuticals Inc
Immunology & Autoimmune
$100.7b$911.22-0.2%643.5K
MRNAMRNAModerna, Inc. Common Stock
Infectious Disease & Vaccines
$91.2b$199.00-2.1%8.4M
AAAgilent Technologies Inc.
Clinical-Stage Platforms
$49.5b$172.17-3.0%1.4M
WATWATWaters Corp
Clinical-Stage Platforms
$45.2b$445.85-3.5%1.2M
IQVIQVIQVIA Holdings Inc.
Clinical-Stage Platforms
$43.3b$251.61-1.9%950.8K
BIIBBIIBBiogen Inc. Common Stock
Neuroscience & CNS
$36.8b$250.00+1.1%711.3K
RPRXRPRXRoyalty Pharma plc Class A Ordinary Shares
Clinical-Stage Platforms
$29.6b$68.52+1.1%2.8M
WSTWSTWest Pharmaceutical Services, Inc.
Clinical-Stage Platforms
$28.4b$390.44-1.6%449.5K
ROIVROIVRoivant Sciences Ltd. Common Shares
Immunology & Autoimmune
$26.0b$38.65-0.8%3.1M
UTHRUTHRUnited Therapeutics Corp
Rare Disease Therapeutics
$25.8b$550.29-0.9%282.0K
INCYINCYIncyte Genomics Inc
Rare Disease Therapeutics
$24.0b$114.75-1.1%1.1M
INSMINSMInsmed, Inc.
Rare Disease Therapeutics
$22.9b$142.50-2.1%5.1M
ALNYALNYAlnylam Pharmaceuticals, Inc.
Rare Disease Therapeutics
$21.4b$144.34-2.8%1.9M
MEDPMEDPMedpace Holdings, Inc. Common Stock
Clinical-Stage Platforms
$18.6b$619.84-3.8%201.4K
RVTYRVTYRevvity, Inc.
Clinical-Stage Platforms
$18.2b$149.47-4.2%1.2M
CRLCRLCharles River Laboratories International, Inc.
Clinical-Stage Platforms
$16.8b$324.55-3.8%865.5K
NBIXNBIXNeurocrine Biosciences Inc
Neuroscience & CNS
$16.8b$161.15-3.8%1.3M
ASNDASNDAscendis Pharma A/S Ordinary Share
Clinical-Stage Platforms
$16.5b$253.10-1.2%454.5K
ICLRICLRIcon Plc
Clinical-Stage Platforms
$15.3b$186.88-1.8%552.3K
JAZZJAZZJazz Pharmaceuticals, Inc.
Neuroscience & CNS
$14.9b$230.66-2.6%724.9K
HALOHALOHalozyme Therapeutics, Inc.
Clinical-Stage Platforms
$14.6b$94.82-1.8%1.1M
BBIOBBIOBridgeBio Pharma, Inc. Common Stock
Rare Disease Therapeutics
$14.4b$76.13-2.7%1.2M
SMMTSMMTSummit Therapeutics Inc. Common Stock
Infectious Disease & Vaccines
$12.6b$10.09-5.8%6.0M
TECHTECHBio-Techne Corp.
Clinical-Stage Platforms
$11.4b$72.85-0.0%3.4M
RGENRGENRepligen Corp
Clinical-Stage Platforms
$11.3b$163.75-3.9%606.9K
KYMRKYMRKymera Therapeutics, Inc. Common Stock
Clinical-Stage Platforms
$10.8b$123.75-3.6%965.4K
BMRNBMRNBioMarin Pharmaceuticals Inc
Rare Disease Therapeutics
$10.8b$60.44-1.6%4.8M
AVTRAVTRAvantor, Inc.
Clinical-Stage Platforms
$10.6b$15.10-1.9%10.5M
QGENQGENQIAGEN N.V.
Clinical-Stage Platforms
$10.4b$49.31-0.7%2.5M
APGEAPGEApogee Therapeutics, Inc. Common Stock
Immunology & Autoimmune
$10.2b$135.090.0%N/A
PCVXPCVXVaxcyte, Inc. Common Stock
Infectious Disease & Vaccines
$9.6b$55.71-5.0%1.4M
TWSTTWSTTwist Bioscience Corporation Common Stock
Clinical-Stage Platforms
$9.3b$104.01-7.4%2.7M
TGTXTGTXTG Therapeutics, Inc.
Neuroscience & CNSImmunology & Autoimmune
$9.3b$63.73-2.4%1.7M
SYRESYRESpyre Therapeutics, Inc. Common Stock
Immunology & Autoimmune
$9.3b$93.55-4.2%625.9K
MDGLMDGLMadrigal Pharmaceuticals, Inc. Common Stock
Metabolic & Cardiometabolic
$9.2b$393.45-4.5%287.8K
PTGXPTGXProtagonist Therapeutics, Inc
Metabolic & CardiometabolicImmunology & Autoimmune
$9.1b$121.46-2.0%515.1K
KRYSKRYSKrystal Biotech, Inc. Common Stock
Rare Disease Therapeutics
$9.0b$308.68-2.3%225.7K
CORTCORTCorcept Therapeutics Inc.
Rare Disease Therapeutics
$8.9b$63.01-2.1%826.7K
CRNXCRNXCrinetics Pharmaceuticals, Inc.
Rare Disease Therapeutics
$8.8b$84.970.0%N/A

Explore Similar Themes